Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study
暂无分享,去创建一个
B. Brochet | P. Cabre | D. Brassat | G. Defer | M. Debouverie | J. Pelletier | L. Taillandier | P. Labauge | B. Audoin | A. Ruet | X. Ayrignac | M. Cohen | J. Ouallet | L. Bauchet | D. Sablot | S. Pittion-Vouyovitch | N. Derache | J. Seze | F. Viala | C. Carra-Dallière | C. Lebrun Frenay | C. Lionnet | A. Siri
[1] Dehui Huang,et al. Clinical and radiological characteristics of 17 Chinese patients with pathology confirmed tumefactive demyelinating diseases: Follow-up study , 2015, Journal of the Neurological Sciences.
[2] K. Kubin,et al. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases. , 2013, European journal of radiology.
[3] Ching-Piao Tsai,et al. Tumefactive Multiple Sclerosis in Taiwan , 2013, PloS one.
[4] A. Mahadevan,et al. Tumefactive demyelination: clinical, imaging and follow‐up observations in thirty‐nine patients , 2013, Acta neurologica Scandinavica.
[5] J. Chataway,et al. Tumefactive demyelination: an approach to diagnosis and management , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[6] C. Boz,et al. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study , 2012, Multiple sclerosis.
[7] T. Taoka,et al. Characteristic Neuroimaging in Patients with Tumefactive Demyelinating Lesions Exceeding 30 mm , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[8] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[9] J. Dastgir,et al. Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal , 2009, Journal of child neurology.
[10] Jeffrey A. Cohen,et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.
[11] W. Brück,et al. Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology , 2008, Journal of Neurology.
[12] W. Brück,et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis , 2008, Brain : a journal of neurology.
[13] D. Taussky,et al. Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposal. , 2006, The Canadian journal of urology.
[14] Jiong Shi,et al. Relapsing-remitting tumefactive multiple sclerosis , 2005, Multiple sclerosis.
[15] H. Staunton,et al. Acute Demyelination, Neuropathological Diagnosis, and Clinical Evolution , 2000, Journal of neuropathology and experimental neurology.
[16] J. Masdeu,et al. Open-ring imaging sign , 2000, Neurology.
[17] Douglas C. Miller,et al. Demyelinating Disease Versus Tumor in Surgical Neuropathology: Clues to a Correct Pathological Diagnosis , 1993, The American journal of surgical pathology.
[18] J. Kepes,et al. Large focal tumor‐like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients , 1993, Annals of neurology.
[19] J. Frahm,et al. Acute demyelinating disease. Classification and non‐invasive diagnosis , 1992, Acta neurologica Scandinavica.
[20] H Okazaki,et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. , 1991, Radiology.
[21] R. Herndon,et al. Multiple sclerosis masquerading as a mass lesion , 2004, Neuroradiology.